CD4 and prostate carcinoma: However, prostate cancer TIL populations are mainly composed of CD4+FOXP3+CD25+ Treg cells and M2-type tumor-associated macrophage (TAM) cells, which contribute to the production of inhibitory cytokines and the maintenance of self-tolerance to suppress the immune response [64].